(Bloomberg Opinion) -- How do you report on a company that may not be all that it claims? That's the question John Carreyrou, two-time Pulitzer Prize winning investigative journalist for the Wall Street Journal, answers on this week's Masters in Business.
The company in question, of course, is Theranos Inc., the tech startup whose founder, Elizabeth Holmes, promised to revolutionize the blood-testing business. The company collapsed after Carreyrou's reporting raised doubts about its technology. Holmes has since been charged with fraud and conspiracy, along with the company's former president.
The entire adventure is told Carreyrou's new best-selling book, “Bad Blood: Secrets and Lies in a Silicon Valley Startup.”
His favorite books are cited here; our conversation transcript is here.
You can stream/download the full conversation, including the podcast extras, on iTunes, Bloomberg, Overcast and Stitcher. Our earlier podcasts can all be found on iTunes, Stitcher, Overcast and Bloomberg.
Next week, we chat with Rob Arnott, chief executive officer and co-founder of investment-research firm Research Affiliates.
To contact the editor responsible for this story: James Greiff at jgreiff@bloomberg.net
This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.
Barry Ritholtz is a Bloomberg Opinion columnist. He founded Ritholtz Wealth Management and was chief executive and director of equity research at FusionIQ, a quantitative research firm. He is the author of “Bailout Nation.”
©2018 Bloomberg L.P.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
